Journal Guide

Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences, in the areas of, but not limited to, cancer biology, clinical cancer research, and cancer prevention.

Cancer Microenvironment is the official journal of the International Cancer Microenvironment Society (ICMS). It publishes original studies in all aspects of basic, clinical and translational research devoted to the study of cancer microenvironment. Topics include: Regulation of gene expression in the cancer microenvironment: innate and adaptive immunity in the cancer microenvironment, inflammation and cancer: tumor-associated stroma & extracellular matrix, tumor-endothelium interactions (angiogenesis, extravasation), cancer stem cells, the metastatic niche, targeting the tumor microenvironment: preclinical and clinical trials. The publication of reports on clinical trials is highly encouraged.

Cancer Nanotechnology is devoted for applications of nanotechnology to oncology. This journal publishes important original studies in the following areas:

· Basic research on the design and development of nanoparticles for oncology
· Interactions of nanoparticles with cancer cells
· Nanodrug delivery system for prevention and therapy of cancer
· Nanoparticles mediated cancer diagnostic systems
· Nanoparticles for therapy of human cancer
· Clinical trials evaluating nanoceuticals

Cancer Nexus is an open-access, peer-reviewed, international journal that publishes high-quality, innovative research in the field of cancer research from clinicians, biomedical scientists, and bioinformatics engineers around the world. The journal focuses on the cutting-edge diagnosis and treatment and mechanism research in the clinical, basic and translational directions of oncology, and focuses on the cross-application of artificial intelligence in cancer clinical and basic research, aiming to establish a bridge of communication between clinical, laboratory and artificial intelligence. The journal is also interested in novel anti-tumor drugs, especially the rational design, screening and efficacy evaluation of AI-assisted anti-tumor drugs.

Cancer Nexus publishes Original Articles, Viewpoint, Case report, Review and Editorial. The journal will consider manuscripts in various fields of cancer and specific areas of interest, including but not limited to clinical trials of novel anti-cancer therapies, clinical epidemiology of cancer based on big data, AI-assisted translational cancer research, minimally invasive and non-invasive integrated diagnosis and treatment technology, cancer bioinformatics, cancer immunology and tumor vaccine development, tumor gene therapy, tumor targeted therapy, cancer omics research, mechanism research on tumor development, development and metastasis.

Cancer Nursing is an international journal providing information on cancer nursing research and care. The primary market is clinical practitioners in cancer nursing who depend on the journal for the excellent research presented in its articles which address the spectrum of problems arising in the care and support of cancer patients.Each bimonthly issue of Cancer Nursing; addresses the whole spectrum of problems arising in the care and support of cancer patients;prevention and early detection, geriatric and pediatric cancer nursing, medical and surgical oncology, ambulatory care, nutritional support, psychosocial aspects of cancer, patient responses to all treatment modalities, and specific nursing interventions. The journal offers unparalleled coverage of cancer care delivery practices worldwide, as well as groundbreaking research findings and their practical applications. For more information, visit www.cancernursingonline.com.

Cancer Prevention Research, the newest journal from the American Association for Cancer Research, is devoted exclusively to cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of oncogenesis, risk factors and risk assessment, early detection research, and chemopreventive and other interventions, including the basic science behind them. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.

Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer.   Subject categories include:

• Basic and Clinical Immunology
• Carcinogenesis
• Cell, Molecular, and Stem Cell Biology
• Clinical Research
• Drug Discovery and Delivery
• Epidemiology and Prevention
• Genetics, Genomics, and Proteomics
• Inflammation and Virology
• Pathology

translational oncology, cancer, clinical oncology, cancer prevention

Cancer Treatment Communications is a new online only open access journal dedicated to publishing communications, case reports and other short form papers that report clinical research, improve clinical practice knowledge in oncology, or address the new challenges of cancer personalized medicine.Articles must be authentic, understandable, educational and clinically interesting to an international audience of medical and surgical oncologists, trainees and researchers in all oncology specialties, as well as clinicians in related fields.All articles submitted are peer reviewed and if accepted for publication, authors are notified of this decision and requested to pay an Article Processing Fee of US $600 / 458 Euro per article (exclusive of UK VAT at 20% which will be charged by Elsevier Ltd). Following payment of this fee, the article will be made open access to all on ScienceDirect and Cancer Treatment Communications.

Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.Each issue provides topical reviews under the following regular sections:• Comments on controversy;• Tumor reviews;• Anti-tumor treatments;• New drugs;• Complications of treatment;• General and supportive care;• Laboratory/clinic interface.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com